Invention Grant
- Patent Title: Influenza virus antibody compositions
-
Application No.: US14342376Application Date: 2012-09-03
-
Publication No.: US09771415B2Publication Date: 2017-09-26
- Inventor: Simon Hufton
- Applicant: Simon Hufton
- Applicant Address: GB London
- Assignee: The Secretary of State for Health
- Current Assignee: The Secretary of State for Health
- Current Assignee Address: GB London
- Agency: Baker & Hostetler LLP
- Priority: GB1115214.7 20110902
- International Application: PCT/GB2012/052164 WO 20120903
- International Announcement: WO2013/030604 WO 20130307
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/395 ; C07K16/00 ; A61K39/00 ; C07K16/28
Abstract:
The present invention relates to unique CDR3 amino acid sequences, and to antibodies comprising said sequences. Also provided are therapeutic applications of said antibodies for use in treating or preventing influenza infection, diagnostic applications of said antibodies for use in detecting influenza virus, potency testing of influenza virus vaccines, and screening applications of said antibodies for use in designing a universal influenza vaccine.
Public/Granted literature
- US20140302063A1 INFLUENZA VIRUS ANTIBODY COMPOSITIONS Public/Granted day:2014-10-09
Information query
